Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative therapies function by mimicking the physiological actions of GLP-1, a hormone secreted https://socialdosa.com/story10740326/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes